Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A

Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunities

(2013) R. J. S. Preston et al.   BLOOD

Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study

(2013) S. C. Gouw et al.   BLOOD

Current status and future prospects for the prophylactic management of hemophilia patients with inhibitor antibodies

(2013) Jerome M. Teitel et al.   BLOOD REVIEWS

A study of prospective surveillance for inhibitors among persons with haemophilia in the United States

(2013) J. M. Soucie et al.   HAEMOPHILIA

Second-generation recombinant factor VIII and inhibitor risk: interpretation of RODIN study findings and implications for patients with haemophilia A

(2013) J. G. van der Bom et al.   HAEMOPHILIA

The Rodin (Research Of Determinants of INhibitor Development among PUPs with haemophilia) study: the clinical conundrum from the perspective of haemophilia treaters

(2013) C. M. Kessler et al.   HAEMOPHILIA

Factor VIII Products and Inhibitors in Severe Hemophilia A

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Factor VIII Products and Inhibitor Development in Severe Hemophilia A

(2013) Samantha C. Gouw et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identifying Nongenetic Risk Factors for Inhibitor Development in Severe Hemophilia A

(2013) Karin Fijnvandraat et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

(2012) J. Astermark et al.   BLOOD

F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis

(2012) S. C. Gouw et al.   BLOOD

In vitrocharacterization of recombinant factor VIII concentrates reveals significant differences in protein content, activity and thrombin activation profile

(2012) S. Pahl et al.   HAEMOPHILIA

F8haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort

(2012) J. Schwarz et al.   HAEMOPHILIA

Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A

(2012) M. E. MANCUSO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Modern haemophilia care

(2012) Erik Berntorp et al.   LANCET

Cumulative inhibitor incidence in previously untreated patients with severe hemophilia A treated with plasma-derived versus recombinant factor VIII concentrates: A critical systematic review

(2011) Massimo Franchini et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Validity of assessing inhibitor development in haemophilia PUPs using registry data: the EUHASS project

(2011) K. FISCHER et al.   HAEMOPHILIA

A case-control study reveals immunoregulatory gene haplotypes that influence inhibitor risk in severe haemophilia A

(2011) J. N. LOZIER et al.   HAEMOPHILIA

Non-genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report

(2010) J. ASTERMARK et al.   HAEMOPHILIA

Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review

(2010) A. IORIO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

EUHASS: The European Haemophilia Safety Surveillance system

(2010) M. Makris et al.   THROMBOSIS RESEARCH

Diagnosis and quantification of factor VIII inhibitors

(2009) B. VERBRUGGEN   HAEMOPHILIA

Cost of care of haemophilia with inhibitors

(2009) M. N. D. DI MINNO et al.   HAEMOPHILIA

Evolution of recombinant factor VIII safety: KOGENATE® and Kogenate® FS/Bayer

(2009) Jeanne M. Lusher et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-α and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A

(2009) A. PAVLOVA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Inhibitors of Factor VIII in Black Patients with Hemophilia

(2009) Kevin R. Viel et al.   NEW ENGLAND JOURNAL OF MEDICINE

How we treat a hemophilia A patient with a factor VIII inhibitor

(2008) C. L. Kempton et al.   BLOOD